Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus

Front Cardiovasc Med. 2023 Mar 9:10:1143652. doi: 10.3389/fcvm.2023.1143652. eCollection 2023.

Authors

Xiaxuan Huang^{1

2}, Luming Zhang^{2

3}, Mengyuan Xu³, Shiqi Yuan^{1

2}, Yan Ye³, Tao Huang², Haiyan Yin³, Jun Lyu^{2

4}

Affiliations

¹ Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
² Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
³ Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, China.
⁴ Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2022.948924.].

Keywords: ICU; acute myocardial infarction; anti-embolic therapy; mortality; type II diabetes mellitus.

© 2023 Huang, Zhang, Xu, Yuan, Ye, Huang, Yin and Lyu.

Publication types

Published Erratum